AU2002324296A1 - Agonists and antagonists of energen for use in the treatment of metabolic disorders - Google Patents

Agonists and antagonists of energen for use in the treatment of metabolic disorders

Info

Publication number
AU2002324296A1
AU2002324296A1 AU2002324296A AU2002324296A AU2002324296A1 AU 2002324296 A1 AU2002324296 A1 AU 2002324296A1 AU 2002324296 A AU2002324296 A AU 2002324296A AU 2002324296 A AU2002324296 A AU 2002324296A AU 2002324296 A1 AU2002324296 A1 AU 2002324296A1
Authority
AU
Australia
Prior art keywords
energen
agonists
antagonists
treatment
metabolic disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002324296A
Inventor
Kristen Briggs
Deno Dialynas
John Lucas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Publication of AU2002324296A1 publication Critical patent/AU2002324296A1/en
Abandoned legal-status Critical Current

Links

AU2002324296A 2001-07-25 2002-07-23 Agonists and antagonists of energen for use in the treatment of metabolic disorders Abandoned AU2002324296A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/308,028 2001-07-25
US60/339,508 2001-12-11

Publications (1)

Publication Number Publication Date
AU2002324296A1 true AU2002324296A1 (en) 2003-02-17

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002339691A1 (en) Agonists and antagonists of prolixin for the treatment of metabolic disorders
HK1109867A1 (en) Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
AU2003223579A1 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
IL159879A0 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
AU2003250831A1 (en) Use of hec1 antagonists in the treatment of proliferative disorders and cancer
AU2962200A (en) Use of agonists or antagonists of mip-3a in therapy
AU2001248971A1 (en) Use of npy y1 receptor agonists in the treatment of pain conditions
AU2002339673A1 (en) Agonists and antagonists of ryzn for the treatment of metabolic disorders
AU2002328173A1 (en) Omoxin agonists and antagonists for use in the treatment of metabolic disorders
AU2002339682A1 (en) Emergen agonists and antagonists for use in the treatment of metabolic disorders
AU2003293500A1 (en) Lactoferrin in the reduction of pain
AU2002339679A1 (en) Glucomin agonists and antagonists for use in the treatment of metabolic disorders
AU2002339689A1 (en) Dexar agonists and antagonists for use in the treatment of metabolic disorders
AU2002324296A1 (en) Agonists and antagonists of energen for use in the treatment of metabolic disorders
AU2002339674A1 (en) Ditacin agonists and antagonists for use in the treatment of metabolic disorders
AU2002334250A1 (en) Xafinix agonists and antagonists for use in the treatment of metabolic disorders
AU2002313578A1 (en) Agonists and antagonists of cofoxin for use in the treatment of metabolic disorders
AU2002313579A1 (en) Agonists and antagonists of famoset for use in the treatment of metabolic disorders
AU2002313581A1 (en) Lypergix agonists and antagonists for use in the treatment of metabolic disorders
AU2002321764A1 (en) Genobix agonists and antagonists for use in the treatment of metabolic disorders
AU2002328172A1 (en) Agonists and antagonists of modumet for use in the treatment of metabolic disorders
AU2002321774A1 (en) Agonists and antagonists of contabix for use in the treatment of metabolic disorders
AU2002324288A1 (en) Agonists and antagonists of genoxin for use in the treatment of metabolic disorders
AU2002324299A1 (en) Genoxit agonists and antagonists for use in the treatment of metabolic disorders